Neisseria meningitidis and Escherichia coli are protected from leukocyte phagocytosis by binding to erythrocyte complement receptor 1 in human blood.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Molecular Immunology

• Publication date

  2011-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.molimm.2011.07.011PMID 21839519PMCID PMC3163737
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors

  2010cited by this paper
• Complement Receptor 1 Expression on Mouse Erythrocytes Mediates Clearance of Streptococcus pneumoniae by Immune Adherence

  2010cited by this paper
• CD14 inhibition efficiently attenuates early inflammatory and hemostatic responses in Escherichia coli sepsis in pigs

  2010cited by this paper
• Complement inhibition decreases the procoagulant response and confers organ protection in a baboon model of Escherichia coli sepsis.

  2010cited by this paper
• A NEW DYNAMIC PORCINE MODEL OF MENINGOCOCCAL SHOCK

  2009cited by this paper
• Innate Immune Responses to Danger Signals in Systemic Inflammatory Response Syndrome and Sepsis

  2009influential reference
• Opening the flood-gates: how neutrophil-endothelial interactions regulate permeability.

  2009cited by this paper
• New Biomarkers in an Acute Model of Live Escherichia coli‐induced Sepsis in Pigs

  2008cited by this paper
• The epidemiology of sepsis.

  2008cited by this paper
• Receptors for complement C5a. The importance of C5aR and the enigmatic role of C5L2

  2008cited by this paper
• Ligation of erythrocyte CR1 induces its clustering in complex with scaffolding protein FAP-1.

  2008cited by this paper
• Experimental Therapeutic Strategies for Severe Sepsis

  2008cited by this paper
• Defining Targets for Complement Components C4b and C3b on the Pathogenic Neisseriae

  2007cited by this paper
• The role of complement C3 opsonization, C5a receptor, and CD14 in E. coli‐induced up‐regulation of granulocyte and monocyte CD11b/CD18 (CR3), phagocytosis, and oxidative burst in human whole blood

  2007cited by this paper
• Epidemic meningitis, meningococcaemia, and Neisseria meningitidis.

  2007cited by this paper
• Hydrophobic effect and hydrogen bonds account for the improved activity of a complement inhibitor, compstatin.

  2006cited by this paper
• Strategies of therapeutic complement inhibition.

  2006cited by this paper
• The Role of Properdin in the Assembly of the Alternative Pathway C3 Convertases of Complement*

  2006cited by this paper
• Use of Robotized DNA Isolation and Real-Time PCR To Quantify and Identify Close Correlation between Levels of Neisseria meningitidis DNA and Lipopolysaccharides in Plasma and Cerebrospinal Fluid from Patients with Systemic Meningococcal Disease

  2005cited by this paper
• Differential effect of heparin coating and complement inhibition on artificial surface-induced eicosanoid production.

  2005cited by this paper
• The dark side of C5a in sepsis

  2004cited by this paper
• Mannose‐binding lectin enhances phagocytosis and killing of Neisseria meningitidis by human macrophages

  2004cited by this paper
• Use of Robotized DNA Isolation and Real-Time PCR To Quantify and Identify Close Correlation between Levels of Neisseria meningitidis DNA and Lipopolysaccharides in Plasma and Cerebrospinal Fluid from Patients with Systemic Meningococcal Disease

  2004cited by this paper
• The epidemiology of sepsis in the United States from 1979 through 2000.

  2003cited by this paper
• Inhibition of C5a-induced inflammation with preserved C5b-9-mediated bactericidal activity in a human whole blood model of meningococcal sepsis.

  2003cited by this paper
• Essential role of the C5a receptor in E coli-induced oxidative burst and phagocytosis revealed by a novel lepirudin-based human whole blood model of inflammation.

  2002cited by this paper
• The role of ficolins in innate immunity.

  2002cited by this paper
• Outer membrane composition of a lipopolysaccharide‐deficient Neisseria meningitidis mutant

  2001cited by this paper
• CR1 and CR1‐like: the primate immune adherence receptors

  2001influential reference
• A Novel Role of Complement: Mice Deficient in the Fifth Component of Complement (C5) Exhibit Impaired Liver Regeneration1

  2001cited by this paper
• Complement Receptor 1/Cd35 Is a Receptor for Mannan-Binding Lectin

  2000cited by this paper
• Interactions of Opsonized Immune Complexes with Whole Blood Cells: Binding to Erythrocytes Restricts Complex Uptake by Leucocyte Populations

  1994cited by this paper
• Quantitative discrimination of hepatic reticuloendothelial clearance and phagocytic killing

  1994cited by this paper
• Erythrocyte complement receptor type 1 and interactions between immune complexes, neutrophils, and endothelium.

  1994cited by this paper
• Role of bacterial association with Kupffer cells in occurrence of endogenous systemic bacteremia

  1991cited by this paper
• Sites within the complement C3b/C4b receptor important for the specificity of ligand binding.

  1991cited by this paper
• Difference in the clustering of complement receptor type 1 (CR1) on polymorphonuclear leukocytes and erythrocytes: Effect on immune adherence

  1990cited by this paper
• Complement activation and endotoxin levels in systemic meningococcal disease.

  1989cited by this paper
• Direct evidence for the clustered nature of complement receptors type 1 on the erythrocyte membrane.

  1988cited by this paper
• The clearance of tetanus toxoid/anti-tetanus toxoid immune complexes from the circulation of humans. Complement- and erythrocyte complement receptor 1-dependent mechanisms.

  1988cited by this paper
• Evaluation of C3b/C3bi opsonization and chemiluminescence with selected yeasts and bacteria using sera of different opsonic potential.

  1986cited by this paper
• Deposition of C3b and iC3b onto particulate activators of the human complement system. Quantitation with monoclonal antibodies to human C3

  1985cited by this paper
• Evidence for distinct intracellular pools of receptors for C3b and C3bi in human neutrophils.

  1985cited by this paper
• Quantification of the Terminal Complement Complex in Human Plasma by an Enzyme‐Linked Immunosorbent Assay Based on Monoclonal Antibodies against a Neoantigen of the Complex

  1985cited by this paper
• Primate erythrocyte-immune complex-clearing mechanism.

  1983cited by this paper
• Unique role of the complement receptor CR1 in the degradation of C3b associated with immune complexes

  1982cited by this paper
• Complement receptor is an inhibitor of the complement cascade

  1981cited by this paper
• Serotypes of Neisseria meningitidis isolated from patients in Norway during the first six months of 1978

  1979cited by this paper
• Regulation of the amplification C3 convertase of human complement by an inhibitory protein isolated from human erythrocyte membrane.

  1979cited by this paper
• The sequential appearance of Ia-like antigens and two different complement receptors during the maturation of human neutrophils

  1978cited by this paper
• Immune Adherence by the Fourth Component of Complement

  1969cited by this paper
• A QUANTITATIVE STUDY OF THE KINETICS OF BLOOD CLEARANCE OF P32-LABELLED ESCHERICHIA COLI AND STAPHYLOCOCCI BY THE RETICULO-ENDOTHELIAL SYSTEM

  1959cited by this paper
• The immune-adherence phenomenon; an immunologically specific reaction between microorganisms and erythrocytes leading to enhanced phagocytosis.

  1953cited by this paper
• “Red-Cell Adhesion” in Trypanosomiasis of Man and Animals

  1930cited by this paper

• Comparative analysis of monocyte distribution width alterations in Escherichia coli sepsis: insights from in vivo and ex vivo models

  2025cites this paper
• Whole-blood model reveals granulocytes as key sites of dengue virus propagation, expanding understanding of disease pathogenesis

  2024cites this paper
• Determinants of bacterial survival and proliferation in blood

  2024cites this paper
• A novel selective leukocyte depletion human whole blood model reveals the specific roles of monocytes and granulocytes in the cytokine response to Escherichia coli.

  2023cites this paper
• SARS‐CoV‐2 triggers complement activation through interactions with heparan sulfate

  2022cites this paper
• Complement C3b contributes to Escherichia coli-induced platelet aggregation in human whole blood

  2022cites this paper
• Application of the C3 inhibitor compstatin in a human whole blood model designed for complement research - 20 years of experience and future perspectives.

  2022cites this paper
• Air Bubbles Activate Complement and Trigger Hemostasis and C3-Dependent Cytokine Release Ex Vivo in Human Whole Blood

  2021cites this paper
• Analysis of mRNA‑lncRNA and mRNA‑lncRNA-pathway co‑expression networks based on WGCNA in developing pediatric sepsis

  2020cites this paper
• Key role of the number of complement receptor 1 on erythrocytes for binding of Escherichia coli to erythrocytes and for leukocyte phagocytosis and oxidative burst in human whole blood.

  2019cites this paper
• Phagocytosis of live and dead Escherichia coli and Staphylococcus aureus in human whole blood is markedly reduced by combined inhibition of C5aR1 and CD14.

  2019cites this paper
• Antibacterial activity of erythrocyte from grass carp (Ctenopharyngodon idella) is associated with phagocytosis and reactive oxygen species generation.

  2019cites this paper
• Bacteria in blood from fibromyalgia patients include the Aquabacterium genus, producing metabolites with inflammatory properties in vitro. Results from a pilot study

  2019cites this paper
• Acoustic impedance matched buffers enable separation of bacteria from blood cells at high cell concentrations

  2018cites this paper
• Evolution of compstatin family as therapeutic complement inhibitors

  2018cites this paper
• In vitro complement activation, adherence to red blood cells and induction of mononuclear cell cytokine production by four strains of Aggregatibacter actinomycetemcomitans with different fimbriation and expression of leukotoxin

  2017cites this paper
• A versatile assay to determine bacterial and host factors contributing to opsonophagocytotic killing in hirudin-anticoagulated whole blood

  2017cites this paper
• Porphyromonas gingivalis‐induced production of reactive oxygen species, tumor necrosis factor‐&agr;, interleukin‐6, CXCL8 and CCL2 by neutrophils from localized aggressive periodontitis and healthy donors: modulating actions of red blood cells and resolvin E1

  2017cites this paper
• Integrated Acoustic Separation, Enrichment, and Microchip Polymerase Chain Reaction Detection of Bacteria from Blood for Rapid Sepsis Diagnostics.

  2016cites this paper
• Comprehensive description of blood microbiome from healthy donors assessed by 16S targeted metagenomic sequencing

  2016cites this paper
• [Blood groups - minuses and pluses. Do the blood group antigens protect us from infectious diseases?].

  2015cites this paper
• The Characterization of Novel Tissue Microbiota Using an Optimized 16S Metagenomic Sequencing Pipeline

  2015cites this paper
• Combined Inhibition of Complement and CD14 Efficiently Attenuated the Inflammatory Response Induced by Staphylococcus aureus in a Human Whole Blood Model

  2014cites this paper
• Meningococcal disease and the complement system

  2013cites this paper
• Knops Blood Group System and the Cost Antigens

  2013cites this paper